ABSTRACT
In Europe, CardioSEAL was awarded the CE mark in September 1997 and is now commercially available.The CE mark signifies that the product has been designed, tested, and manufactured in a manner which demonstrates safe use in humans. In the US, the CardioSEAL device is only approved for ventricular septal defects, but is used in an off-label fashion for patent foramen ovale.
